Has it come to the time to recommend routine use of alirocumab in patients with acute coronary syndrome?

Chia Siang Kow; Abdullah Faiz Zaihan; Syed Shahzad Hasan

doi:10.1093/eurjpc/zwaa148

Has it come to the time to recommend routine use of alirocumab in patients with acute coronary syndrome?

Chia Siang Kow, Abdullah Faiz Zaihan, Syed Shahzad Hasan

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e77-e78
Number of pages	2
Journal	European Journal of Preventive Cardiology
Volume	29
Issue number	2
Early online date	28 Dec 2020
DOIs	https://doi.org/10.1093/eurjpc/zwaa148
Publication status	Published - 1 Jan 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/eurjpc/zwaa148Licence: Unspecified

Cite this

@article{315b294aae5441cdb3cfc90506345a10,

title = "Has it come to the time to recommend routine use of alirocumab in patients with acute coronary syndrome?",

keywords = "alirocumab, acute coronary syndrome",

author = "Kow, {Chia Siang} and Zaihan, {Abdullah Faiz} and Hasan, {Syed Shahzad}",

year = "2022",

month = jan,

day = "1",

doi = "10.1093/eurjpc/zwaa148",

language = "English",

volume = "29",

pages = "e77--e78",

journal = "European Journal of Cardiovascular Prevention and Rehabilitation",

issn = "2047-4873",